Investigating genetic regulators of Mycobacterium tuberculosis cell division and their role in persistent tuberculosis infection
研究结核分枝杆菌细胞分裂的遗传调节因子及其在持续性结核感染中的作用
基本信息
- 批准号:10604773
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:Actinobacteria classAcuteAffectAlanineAntibioticsBacteriaBacterial InfectionsBinding SitesCRISPR interferenceCell Division ProcessCell WallCell divisionCellsCellular StructuresChromosome SegregationChronicComplexDNA BindingDataDefectDevelopmentDisease modelDrug TargetingEssential GenesGene ExpressionGenesGeneticGenomicsGoalsGranulomaGrowthGuide RNAHomologous GeneHost DefenseImmuneImmune responseImpairmentIn VitroInfectionLeadMacrophageMethodsMicroscopyModelingMorphologyMusMycobacterium tuberculosisOrganismPathogenesisPersonsPhagosomesPhenotypePlayPopulationPopulation HeterogeneityProcessProliferatingProteinsRegulationRegulatory PathwayRegulonReplication-Associated ProcessRepressionRoleSagittariaStainsStressStructureTechnologyTestingTetracyclinesTherapeuticTranslatingTuberculosisVisualizationWorkadaptive immune responseanalogcellular imagingdaughter cellgene functiongene repressiongenetic technologyhuman pathogenimprovedin vivoinsightknock-downmetermouse modelmutantmycobacterialnovelnutrient deprivationpathogensuccesstranscription factortuberculosis drugs
项目摘要
PROJECT SUMMARY/ABSTRACT
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, has infected about one-quarter of the
global population and kills over 1 million people every year. Mtb is an exceptionally successful human pathogen
largely because the bacteria can adapt to withstand several different stresses in vivo and can enter a state of
replicative quiescence where Mtb can persist for months to years. This presents major challenges to treating
tuberculosis as many anti-tubercular drugs target bacterial replication and cell wall synthesis. Mtb have a unique
mechanism of division where the bacteria grow asymmetrically and produce daughter cells that vary in size,
growth rate, and cell wall composition. This contrasts with cell division processes employed by other well-studied
bacteria, and Mtb possess distinct cellular machinery and regulatory pathways to coordinate their cell division.
Thus, it is critical to understand Mtb’s unique mechanism of replication, how it is regulated, and how it contributes
to bacterial pathogenesis. The overall goal of this proposal is to elucidate two novel regulatory networks that
control Mtb cell division, and to understand the role this regulation plays during tuberculosis infection when Mtb
slow or halt their growth. I hypothesize that the uncharacterized transcription factors WhiA and WhiB2 are
essential regulators of cell division in Mtb, and that both proteins are required for maintaining bacterial viability
in vivo, even during persistent tuberculosis infection when the bacteria enter a slow or non-replicative state. This
proposal seeks to i) utilize novel CRISPR interference technology in Mtb to interrogate the function of two
essential and previously uncharacterized genes, ii) define two regulons that are critical for regulating cell division
in Mtb, and iii) determine the importance of these regulatory networks during persistent tuberculosis infection.
These aims employ phenotypically relevant models of Mtb infection, including macrophage and mouse models
of disease. Successful completion of this proposal will advance the field by elucidating how Mtb regulate cell
division and provide insight into how these regulatory pathways contribute to Mtb’s persistence and survival in
vivo. Understanding mechanisms of Mtb replication and persistence can aid with improving and developing
therapeutics for treating tuberculosis.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frances Marks其他文献
Frances Marks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Standard Grant














{{item.name}}会员




